Special Stain, Congo Red
There are several proteins produced by the human cell and these have to be folded into appropriate configuration in order to function properly. This process is carried out after translation.
However, there are many circumstances where the newly synthesized protein is misfolded and cannot carry out the designated function. Misfolded proteins are normally refolded by molecular chaperones or degraded through the ubiquitin-proteasome system. However, persistent misfolding can result in insoluble extracellular deposits termed amyloid which can disrupt the normal architecture and function of organs. This condition is called amyloidosis.
Amyloid fibrils share a common cross-β-pleated sheet structure regardless of their protein precursor. Over 30 proteins have been identified as amyloids and the major types include: AL (light chain amyloidosis): derived from immunoglobulin light chains, commonly associated with plasma cell dyscrasias, AA (amyloid A): derived from serum amyloid A protein, often secondary to chronic inflammation or infection, ATTR (transthyretin): hereditary (mutated TTR) or wild-type, associated with cardiomyopathy and neuropathy, and Aβ (amyloid-beta): found in Alzheimer’s disease plaques and cerebral amyloid angiopathy.
Congo Red is a special stain that binds specifically to the beta-sheet structure of amyloid fibrils and is the traditional gold standard for identifying amyloid. When stained and viewed under light microscopy, amyloid appears as amorphous, pink-red, eosinophilic, extracellular deposits. Under polarized light, a distinctive apple-green birefringence is observed, confirming amyloid deposition. This optical phenomenon results from the alignment of Congo red dye molecules along the parallel beta-pleated sheets of the amyloid fibrils, a feature not observed in other protein deposits or fibrosis. Because Congo Red staining only confirms the presence of amyloid but not the subtype, further characterization is required (immunohistochemistry, immunofluorescence, laser microdissection with mass spectrometry, or genetic testing). Subtyping is critical for guiding therapy (e.g., chemotherapy for AL vs. tafamidis for ATTR).
- Primary diagnostic tool for histologic confirmation of amyloidosis
- As an aid in the diagnosis of Alzheimer’s disease
- Differentiation of amyloid from other eosinophilic tissue deposits (e.g., hyaline, scar tissue, fibrinoid).
Positive: Pink-red amorphous, extracellular deposits under light-microscopy and apple-red birefringence under polarized microscopy.
Negative: Absence of Congo Red-positive deposits.
False positives can result from collagen or elastin showing birefringence.
Confirmation with immunohistochemistry or mass spectrometry is strongly recommended for clinical decision-making.
Normal: Negative for amyloid deposition
Formalin-fixed paraffin-embedded (FFPE) tissue.
Alternatives: Cell block, fat aspirate, organ biopsy (renal, cardiac, rectal).
Stability
- Ambient: Indefinite
- Refrigerated: Indefinite
- Frozen: Unacceptable (damages tissue morphology and staining quality)
- Ann Med. 2022 Dec;54(1):2511-2516. [PMID: 36120888]
- Hum Pathol. 2014 Aug;45(8):1766-72. [PMID: 24935061]
- Int J Exp Pathol. 2019 Aug;100(4):208-221. [PMID: 31515863]
- Biosci Rep. 2019 Jan 15;39(1):BSR20181415. [PMID: 30567726]